Author Archives: Margarida Azevedo, MSc

Alexion Receives Positive Opinion from EU’s CHMP for Soliris to Treat Subgroup of gMG Patients

Alexion Pharmaceuticals has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion to extend the approved indication of Soliris (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) to patients who are anti-acetylcholine receptor (AChR)…